Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity.
- Total Shares Purchased: 3,251,858 ordinary shares
- Purchase Date: September 24, 2025
- Price Range: 327.60p to 332.40p per share
- Volume Weighted Average Price: 330.4723p (LSE) and 330.2795p (CBOE)
- Treasury Shares Held: 36,589,403 shares post-settlement
- Voting Shares Outstanding: 8,915,764,245 shares
Material Changes
This transaction represents the second tranche of a share buyback programme announced on July 31, 2025. The purchase reduces the number of shares with voting rights and increases the company's treasury share holdings.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It is a regulatory disclosure of a completed share transaction.
Investor Verification Checklist
- Verify the total number of shares purchased (3,251,858) against the company's total buyback programme authorization.
- Confirm the updated count of treasury shares (36,589,403) and voting shares (8,915,764,245) for disclosure threshold calculations.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular execution details.
- Note that this filing does not contain financial performance data; refer to the most recent Form 20-F or quarterly earnings release for revenue and profit metrics.